Gene Wojciechowski was let go during ESPN's layoffs in 2023, but that didn't stop an array of tributes to his career over the weekend. Sports newsletter 🏈's best, via 📧 Studio IX 🏀⚽️ ...

Researchers say they can improve rice harvests and grain quality by essentially turning off a temperature-sensitive gene found in some common rice varieties.

It's official: Gene Wojciechowski is no longer an official part of ESPN. Wojciechowski made the announcement this weekend on X (formerly Twitter): "After 27 1/2 yrs, my official last day on the ...

Gene L. Rooze, 89, of West Lafayette, passed away on Saturday, May 24, 2025, at Westminster Village. He was born January 20, 1936, in Montmorenci, IN, to the late Rena and Marie (Mills) Rooze.

Wiley Eugene “Gene” Brookshire Funeral services for Wiley Eugene “Gene” Brookshire of Lufkin will be held Saturday, May 31, 2025 at 11:00 a.m. in the Carroway Funeral Home Chapel. Pastor Bob Klund, ...

Cell and Gene Therapy Market Size, Growth Report 2025-2033Cell and Gene Therapy Market size reached US$ 13.90 Billion in 2024 and is expected to reach US$ 105.83 Billion by 2033 ...

SCARBOROUGH - Gene Griffin, 94, passed away on May 31, 2025, at the Maine Veteran’s Home with his family by his ... SCARBOROUGH – Gene Griffin, 94, passed away on May 31, 2025, at the Maine ...

Leaders from the world of cell and gene therapy, including molecular geneticists, immunotherapists, physicians, nonprofit directors, and patient advocates, shared their personal stories and policy ...

Gene Deal, Diddy’s former bodyguard, was banned from the rapper’s trial after allegedly knocking out a YouTuber outside a NYC courthouse.

The gene therapy technology was licensed by UC San Diego to Eikonoklastes Therapeutics in 2021. Eikonoklastes was granted Orphan Drug Designation (ODD) by the FDA for the use of the patented gene ...

Five people were injured in a multi-vehicle crash on the Gene Snyder Freeway Sunday afternoon, according to Louisville Metro Police.Around 2 p.m., TRIMARC reported that two vehicles were involved ...

Next-generation gene-editing therapies are advancing in the clinic, but many companies in the field are early-stage, high-risk enterprises—not the profile that investors and pharma are seeking ...